242 related articles for article (PubMed ID: 17363423)
1. Carbapenem resistance in Bacteroides fragilis.
Ang L; Brenwald NP; Walker RM; Andrews J; Fraise A
J Antimicrob Chemother; 2007 May; 59(5):1042-4. PubMed ID: 17363423
[No Abstract] [Full Text] [Related]
2. Antibiotic susceptibility profiles of European Bacteroides fragilis with reduced carbapenem susceptibility.
Hawser SP; Hackel M; Hoban DJ
J Antimicrob Chemother; 2010 Apr; 65(4):803-4. PubMed ID: 20130025
[No Abstract] [Full Text] [Related]
3. In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains.
Betriu C; Sánchez A; Palau ML; Gómez M; Picazo JJ
Antimicrob Agents Chemother; 2001 Aug; 45(8):2372-4. PubMed ID: 11451700
[TBL] [Abstract][Full Text] [Related]
4. Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey.
Sóki J; Edwards R; Hedberg M; Fang H; Nagy E; Nord CE;
Int J Antimicrob Agents; 2006 Dec; 28(6):497-502. PubMed ID: 17097857
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Snydman DR; Jacobus NV; McDermott LA
Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
[TBL] [Abstract][Full Text] [Related]
6. New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea.
Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Jeong SH; Lee K; Kim JM; Chong Y
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):343-8. PubMed ID: 20226324
[TBL] [Abstract][Full Text] [Related]
7. High rates of reduced susceptibility in the Bacteroides fragilis group isolated from blood cultures--the first national survey in Denmark.
Justesen US; Hansen F; Østergaard C; Schønheyder HC; Hansen DS; Lemming LE; Schumacher H; Heltberg O; Knudsen JD; Dzajic E; Arpi M; Hammerum AM
Int J Antimicrob Agents; 2013 Aug; 42(2):188-90. PubMed ID: 23773329
[No Abstract] [Full Text] [Related]
8. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
[TBL] [Abstract][Full Text] [Related]
9. The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.
Goldstein EJ; Citron DM; Tyrrell KL; Leoncio ES; Merriam CV
Anaerobe; 2017 Feb; 43():1-3. PubMed ID: 27713022
[TBL] [Abstract][Full Text] [Related]
10. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.
Katsandri A; Papaparaskevas J; Pantazatou A; Petrikkos GL; Thomopoulos G; Houhoula DP; Avlamis A
J Clin Microbiol; 2006 Sep; 44(9):3465-7. PubMed ID: 16954304
[TBL] [Abstract][Full Text] [Related]
11. The first characterized carbapenem-resistant Bacteroides fragilis strain from Croatia and the case study for it.
Bogdan M; Perić L; Ördög K; Vuković D; Urbán E; Sóki J
Acta Microbiol Immunol Hung; 2018 Aug; 65(3):317-323. PubMed ID: 29651861
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital.
Toprak NU; Uzunkaya OD; Sóki J; Soyletir G
Anaerobe; 2012 Feb; 18(1):169-71. PubMed ID: 22063500
[TBL] [Abstract][Full Text] [Related]
13. A new insertion sequence element containing a cfiA gene in the first imipenem-resistant Bacteroides fragilis strain isolated in Italy.
Cascio GL; Macaccaro L; Centonze AR; Sóki J; Fontana R; Mazzariol A
Int J Antimicrob Agents; 2009 Dec; 34(6):610-1. PubMed ID: 19744834
[No Abstract] [Full Text] [Related]
14. First Hungarian case of an infection caused by multidrug-resistant Bacteroides fragilis strain.
Urbán E; Horváth Z; Sóki J; Lázár G
Anaerobe; 2015 Feb; 31():55-8. PubMed ID: 25285854
[TBL] [Abstract][Full Text] [Related]
15. Potential factors influencing carbapenem activity against Bacteroides fragilis group isolates.
Iaconis JP; Nadler HL; Sheikh W
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S361-3. PubMed ID: 7548598
[No Abstract] [Full Text] [Related]
16. Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections.
Claros M; Citron DM; Goldstein EJ; Merriam CV; Tyrrell KL
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):546-8. PubMed ID: 23727512
[TBL] [Abstract][Full Text] [Related]
17. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.
Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Rihs J; Gorbach SL
Clin Infect Dis; 2002 Sep; 35(Suppl 1):S126-34. PubMed ID: 12173121
[TBL] [Abstract][Full Text] [Related]
18. Multiple mobile promoter regions for the rare carbapenem resistance gene of Bacteroides fragilis.
Podglajen I; Breuil J; Rohaut A; Monsempes C; Collatz E
J Bacteriol; 2001 Jun; 183(11):3531-5. PubMed ID: 11344163
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of enterotoxin and antibiotic resistance genes in clinical and intestinal Bacteroides fragilis group isolates in Turkey.
Kangaba AA; Saglam FY; Tokman HB; Torun M; Torun MM
Anaerobe; 2015 Oct; 35(Pt B):72-6. PubMed ID: 26219215
[TBL] [Abstract][Full Text] [Related]
20. Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan.
Sherwood JE; Fraser S; Citron DM; Wexler H; Blakely G; Jobling K; Patrick S
Anaerobe; 2011 Aug; 17(4):152-5. PubMed ID: 21376821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
